Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001232524-24-000022
Filing Date
2024-04-26
Accepted
2024-04-26 16:39:26
Documents
23
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A jazz-20231231.htm   iXBRL 10-K/A 1286525
2 EX-31.3 exhibit313.htm EX-31.3 5765
3 EX-31.4 exhibit314.htm EX-31.4 5447
7 jazz-20231231_g1.jpg GRAPHIC 35999
8 jazz-20231231_g2.jpg GRAPHIC 18757
9 jazz-20231231_g3.jpg GRAPHIC 18559
10 jazz-20231231_g4.jpg GRAPHIC 18114
11 jazz-20231231_g5.jpg GRAPHIC 48376
12 jazz-20231231_g6.jpg GRAPHIC 58635
13 jazz-20231231_g7.jpg GRAPHIC 60301
  Complete submission text file 0001232524-24-000022.txt   2328262

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jazz-20231231.xsd EX-101.SCH 2535
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jazz-20231231_lab.xml EX-101.LAB 39253
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jazz-20231231_pre.xml EX-101.PRE 23073
27 EXTRACTED XBRL INSTANCE DOCUMENT jazz-20231231_htm.xml XML 7953
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33500 | Film No.: 24884573
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)